specifies the probability of incorrectly deciding that a shift has occurred when the process mean is equal to the target mean. This is known as the probability of a ...
Of 882 participants enrolled, 128 had PD-L1 CPS < 1 and 373 had CPS 1-19. For pembrolizumab versus cetuximab-chemotherapy, the median overall survival was 7.9 versus 11.3 months in the PD-L1 CPS < 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results